{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:38:42Z","timestamp":1761896322667,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Psiquiatr\u00eda  y Salud Mental"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.rpsm.2016.03.005","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T03:20:51Z","timestamp":1462332051000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Aumento en los recuentos de leucocitos y neutr\u00f3filos durante las primeras 18 semanas de tratamiento con clozapina en pacientes ingresadas en una unidad de cuidados psiqui\u00e1tricos prolongados"],"prefix":"10.1016","volume":"11","author":[{"given":"Adri\u00e1n","family":"Capllonch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"de Pablo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpsm.2016.03.005_bib0065","first-page":"429","article-title":"Clozapine-induced transient white blood count disorders","volume":"55","author":"Hummer","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rpsm.2016.03.005_bib0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rpsm.2016.03.005_bib0075","unstructured":"Elizondo Armend\u00e1riz JJ. Clozapina: una visi\u00f3n hist\u00f3rica y papel actual en la esquizofrenia resistente al tratamiento. Ars Pharm. 2008; 49:135-144."},{"key":"10.1016\/j.rpsm.2016.03.005_bib0080","unstructured":"Madrid Ministerio de Sanidad y Consumo. Circular n.o 10\/93 de la Direcci\u00f3n General de Farmacia y productos sanitarios sobre reglamentaci\u00f3n espec\u00edfica para la prescripci\u00f3n, dispensaci\u00f3n y utilizaci\u00f3n de leponex. 1993 [consultado 3 Dic 2014]. . Disponible en: http:\/\/www.ub.edu\/legmh\/disposici\/cir1093.htm"},{"year":"2014","series-title":"Nemea (clozapina) ficha t\u00e9cnica","key":"10.1016\/j.rpsm.2016.03.005_bib0085"},{"year":"2015","series-title":"Clozaril (clozapine) package insert","key":"10.1016\/j.rpsm.2016.03.005_bib0090"},{"year":"2014","series-title":"FazaClo (clozapine) package insert","key":"10.1016\/j.rpsm.2016.03.005_bib0095"},{"key":"10.1016\/j.rpsm.2016.03.005_bib0100","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-7-635","article-title":"Use of lithium in clozapine-induced neutropenia: A case report","volume":"7","author":"Suraweera","year":"2014","journal-title":"BMC Res Notes."},{"key":"10.1016\/j.rpsm.2016.03.005_bib0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13651500903402450","article-title":"Incidence and risk for neutropenia\/agranulocytosis among clozapine users: A retrospective cohort study","volume":"14","author":"Ratanajamit","year":"2010","journal-title":"Int J Psychiatry Clin Pract."},{"key":"10.1016\/j.rpsm.2016.03.005_bib0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2011.10.014","article-title":"When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature","volume":"134","author":"Manu","year":"2012","journal-title":"Schizophr Res."},{"key":"10.1016\/j.rpsm.2016.03.005_bib0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.rpsm.2011.11.003","article-title":"Clozapina y agranulocitosis en Espa\u00f1a: \u00bftenemos una poblaci\u00f3n m\u00e1s segura? Seguimiento hematol\u00f3gico a 5 a\u00f1os de una cohorte de pacientes tratados con clozapina","volume":"5","author":"Pons","year":"2012","journal-title":"Rev Psiquiatr Salud Ment (Barc)."},{"key":"10.1016\/j.rpsm.2016.03.005_bib0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.jcp.0000177668.42640.fe","article-title":"Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients","volume":"25","author":"Fehsel","year":"2005","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Revista de Psiquiatr\u00eda  y Salud Mental"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888989116300027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888989116300027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:32:11Z","timestamp":1761823931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1888989116300027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1888989116300027"],"URL":"https:\/\/doi.org\/10.1016\/j.rpsm.2016.03.005","relation":{},"ISSN":["1888-9891"],"issn-type":[{"type":"print","value":"1888-9891"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aumento en los recuentos de leucocitos y neutr\u00f3filos durante las primeras 18semanas de tratamiento con clozapina en pacientes ingresadas en una unidad de cuidados psiqui\u00e1tricos prolongados","name":"articletitle","label":"Article Title"},{"value":"Revista de Psiquiatr\u00eda  y Salud Mental","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpsm.2016.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SEP y SEPB. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}